Halozyme Therapeutics Inc. buy TD Cowen
Start price
18.02.26
/
50%
€61.94
Target price
18.02.27
-
Performance (%)
-4.94%
Price
17.04.26
€58.88
Summary
This prediction is currently active. With a performance of -4.94%, the BUY prediction for Halozyme Therapeutics Inc. by TD_Cowen is down slightly. This prediction currently runs until 18.02.27. The prediction end date can be changed by TD_Cowen at any time. TD_Cowen has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Halozyme Therapeutics Inc. | 1.798% | 1.798% |
| iShares Core DAX® | 3.593% | 3.931% |
| iShares Nasdaq 100 | 5.810% | 5.518% |
| iShares Nikkei 225® | 4.075% | 8.460% |
| iShares S&P 500 | 4.142% | 4.039% |
Comments by TD_Cowen for this prediction
In the thread Halozyme Therapeutics Inc. diskutieren
Halozyme Therapeutics (NASDAQ:HALO) had its "buy" rating reaffirmed by analysts at TD Cowen.
Ratings data for HALO provided by MarketBeat
Stopped prediction by TD_Cowen for Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€62.16
08.01.26
08.01.26
€77.09
08.01.27
08.01.27
-5.28%
17.04.26
17.04.26
